‘Celebrex’ developed the most for bioequivalently approved generics last year

Published: 2016-02-02 15:49:01

Updated: 2016-02-02 15:49:01

A pharmaceutical product which was developed as generics by the most number of pharmaceutical companies was ‘Celebrex’ last year.

According to the Medipana News’ analysis result of the Ministry of Food and Drug Safety’s official announcement for bioequivalence approvals on the 1^st, there were the total 1,216 products increased by 138 products compared to the year before.

The phenomenon can be...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.